231 related articles for article (PubMed ID: 23320987)
41. Shear stress decreases endothelial cell tissue factor activity by augmenting secretion of tissue factor pathway inhibitor.
Grabowski EF; Reininger AJ; Petteruti PG; Tsukurov O; Orkin RW
Arterioscler Thromb Vasc Biol; 2001 Jan; 21(1):157-62. PubMed ID: 11145948
[TBL] [Abstract][Full Text] [Related]
42. The effect of leukocyte elastase on tissue factor pathway inhibitor.
Higuchi DA; Wun TC; Likert KM; Broze GJ
Blood; 1992 Apr; 79(7):1712-9. PubMed ID: 1558967
[TBL] [Abstract][Full Text] [Related]
43. Formation of tissue factor-factor VIIa-factor Xa complex prevents apoptosis in human breast cancer cells.
Jiang X; Guo YL; Bromberg ME
Thromb Haemost; 2006 Aug; 96(2):196-201. PubMed ID: 16894464
[TBL] [Abstract][Full Text] [Related]
44. Tissue Factor/ FVIIa prevents the extrinsic pathway of apoptosis by regulation of the tumor suppressor Death-Associated Protein Kinase 1 (DAPK1).
Aberg M; Johnell M; Wickström M; Siegbahn A
Thromb Res; 2011 Feb; 127(2):141-8. PubMed ID: 21168190
[TBL] [Abstract][Full Text] [Related]
45. Expression, localization, and activity of tissue factor pathway inhibitor in normal and atherosclerotic human vessels.
Crawley J; Lupu F; Westmuckett AD; Severs NJ; Kakkar VV; Lupu C
Arterioscler Thromb Vasc Biol; 2000 May; 20(5):1362-73. PubMed ID: 10807755
[TBL] [Abstract][Full Text] [Related]
46. Vascular endothelial growth factor production by fibroblasts in response to factor VIIa binding to tissue factor involves thrombin and factor Xa.
Ollivier V; Chabbat J; Herbert JM; Hakim J; de Prost D
Arterioscler Thromb Vasc Biol; 2000 May; 20(5):1374-81. PubMed ID: 10807756
[TBL] [Abstract][Full Text] [Related]
47. Activated factor X and thrombin formation triggered by tissue factor on endothelial cell matrix in a flow model: effect of the tissue factor pathway inhibitor.
van 't Veer C; Hackeng TM; Delahaye C; Sixma JJ; Bouma BN
Blood; 1994 Aug; 84(4):1132-42. PubMed ID: 8049429
[TBL] [Abstract][Full Text] [Related]
48. Down-regulation of monocyte tissue factor mediated by tissue factor pathway inhibitor and the low density lipoprotein receptor-related protein.
Hamik A; Setiadi H; Bu G; McEver RP; Morrissey JH
J Biol Chem; 1999 Feb; 274(8):4962-9. PubMed ID: 9988740
[TBL] [Abstract][Full Text] [Related]
49. Study of factor VII, tissue factor pathway inhibitor and monocyte tissue factor in noninsulin-dependent diabetes mellitus.
El-Ghoroury EA; El-Din HG; Abdel-Kader M; Ragab S
Blood Coagul Fibrinolysis; 2008 Jan; 19(1):7-13. PubMed ID: 18180609
[TBL] [Abstract][Full Text] [Related]
50. Penthalaris, a novel recombinant five-Kunitz tissue factor pathway inhibitor (TFPI) from the salivary gland of the tick vector of Lyme disease, Ixodes scapularis.
Francischetti IM; Mather TN; Ribeiro JM
Thromb Haemost; 2004 May; 91(5):886-98. PubMed ID: 15116248
[TBL] [Abstract][Full Text] [Related]
51. Tissue factor pathway inhibitor-gamma is an active alternatively spliced form of tissue factor pathway inhibitor present in mice but not in humans.
Maroney SA; Ferrel JP; Collins ML; Mast AE
J Thromb Haemost; 2008 Aug; 6(8):1344-51. PubMed ID: 18503630
[TBL] [Abstract][Full Text] [Related]
52. Tissue factor pathway inhibitor inhibits aortic smooth muscle cell migration induced by tissue factor/factor VIIa complex.
Sato Y; Asada Y; Marutsuka K; Hatakeyama K; Kamikubo Y; Sumiyoshi A
Thromb Haemost; 1997 Sep; 78(3):1138-41. PubMed ID: 9308767
[TBL] [Abstract][Full Text] [Related]
53. Probable regulation of factor VIIa-tissue factor and prothrombinase by factor Xa-TFPI and TFPI in vivo.
Gouin-Thibault I; Dewar L; Craven S; Kulczycky M; Wun TC; Ofosu FA
Br J Haematol; 1996 Dec; 95(4):738-46. PubMed ID: 8982054
[TBL] [Abstract][Full Text] [Related]
54. Regulation of tissue factor initiated thrombin generation by the stoichiometric inhibitors tissue factor pathway inhibitor, antithrombin-III, and heparin cofactor-II.
van 't Veer C; Mann KG
J Biol Chem; 1997 Feb; 272(7):4367-77. PubMed ID: 9020158
[TBL] [Abstract][Full Text] [Related]
55. The role of microRNA-27a/b and microRNA-494 in estrogen-mediated downregulation of tissue factor pathway inhibitor α.
Ali HO; Arroyo AB; González-Conejero R; Stavik B; Iversen N; Sandset PM; Martínez C; Skretting G
J Thromb Haemost; 2016 Jun; 14(6):1226-37. PubMed ID: 26999003
[TBL] [Abstract][Full Text] [Related]
56. Formation of tissue factor-factor VIIa-factor Xa complex induces activation of the mTOR pathway which regulates migration of human breast cancer cells.
Jiang X; Zhu S; Panetti TS; Bromberg ME
Thromb Haemost; 2008 Jul; 100(1):127-33. PubMed ID: 18612547
[TBL] [Abstract][Full Text] [Related]
57. Localization of tissue factor pathway inhibitor to lipid rafts is not required for inhibition of factor VIIa/tissue factor activity.
Dietzen DJ; Jack GG; Page KL; Tetzloff TA; Hall CL; Mast AE
Thromb Haemost; 2003 Jan; 89(1):65-73. PubMed ID: 12540955
[TBL] [Abstract][Full Text] [Related]
58. Protein and mRNA expression of tissue factor pathway inhibitor-1 (TFPI-1) in breast, pancreatic and colorectal cancer cells.
Kurer MA
Mol Biol Rep; 2007 Dec; 34(4):221-4. PubMed ID: 17180732
[TBL] [Abstract][Full Text] [Related]
59. Functional and immunologic methods for the measurement of human tissue factor pathway inhibitor.
Bognacki J; Hammelburger J
Blood Coagul Fibrinolysis; 1995 Jun; 6 Suppl 1():S65-72. PubMed ID: 7647224
[TBL] [Abstract][Full Text] [Related]
60. Opposite regulation by PI3K/Akt and MAPK/ERK pathways of tissue factor expression, cell-associated procoagulant activity and invasiveness in MDA-MB-231 cells.
Hu C; Huang L; Gest C; Xi X; Janin A; Soria C; Li H; Lu H
J Hematol Oncol; 2012 Jul; 5():16. PubMed ID: 22534171
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
